Invoice Finance for Pharmaceuticals & Life Sciences UK

Market Invoice is an independent UK invoice finance comparison site that helps UK pharmaceutical contract manufacturers, generics distributors, GMP-licensed packers and pharma logistics firms find the right factoring partner.

UK pharmaceutical and life sciences supply chains operate on long payment cycles. NHS Trusts and Integrated Care Boards pay 60-90 days; big pharma OEMs (GSK, AstraZeneca, Pfizer UK, Haleon) often net-90; international distributors net-60 to net-120. Meanwhile MHRA and GMP compliance, raw API costs, validated cleanrooms, and trained QP-supervised staff are all due upfront. Invoice finance advances 75-90% of completed-batch invoices within 24 hours. The product suits contract manufacturers (CMOs), generics importers and distributors, GMP-licensed packagers, cold-chain logistics, and pharma trial supply firms. Available from £50,000 turnover.

Last updated: 5 May 2026.

The pharma supply chain cash flow problem

A typical CMO contract: client orders a 500,000-unit batch. CMO procures API and excipients (~30% of batch value), runs validated production, conducts QP release, and ships. The whole production cycle takes 8-12 weeks. Final invoice goes to the client (often big pharma or a generics distributor) at end of release. Client pays 60-90 days later. The CMO has funded API + payroll + validated facility costs for nearly 6 months before the cash lands.

Invoice finance shortens that gap from 6 months to 24 hours per batch. For NHS suppliers, the same dynamic applies — order placed, product delivered, invoice raised, NHS pays 60-90 days later.

What's different for pharma

• QP release as invoice trigger: Most providers will only advance after Qualified Person release. Build the QP sign-off into your billing milestones from contract stage.
• NHS as debtor: NHS Trusts and ICBs are top-tier debtors — providers offer near-best terms when invoicing the NHS supply chain. Care Quality Commission and registered NHS framework status strengthens underwriting.
• API and excipient prefinance: Some providers offer purchase order finance alongside invoice finance for high-value API procurement. Bibby and Aldermore strongest at bundled facilities.
• International payment: If you export pharma to EU/US/RoW, multi-currency invoice finance prevents FX risk on large balances. HSBC, Bibby and Close Brothers cover 60+ countries.
• MHRA + GMP licence: Providers don't audit your MHRA compliance; the licence protects your debtor relationships.

Providers experienced with UK pharma supply chain